Skip to main content
MMedVellum
MCQsExamsAtlas
DashboardPricing
MMedVellum

The exam atlas that feels like a flagship product — evidence-graded topics and exam tools for MBBS and fellowship preparation. Built to scale to fifty specialties. Educational content only — not medical advice.

llms.txt·psychiatry LLM catalog · sitemap

Atlas

  • Specialty atlas
  • MBBS / Core medicine
  • Dermatology
  • ICU Fellowship (CICM)
  • Anaesthesia
  • Emergency Medicine
  • Psychiatry Fellowship

Study & account

  • MCQ practice
  • Practice alias
  • Exam tools
  • Dashboard
  • Pricing
  • Sign in

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

Clinical Atlas Prestige · Evidence-first

Psych CASC / OSCEGeneral adult psychiatry — mood disorders

Psych CASC / OSCE · General adult psychiatry — mood disorders

Explain treatment-resistant depression and next-step options — CASC communication station

MRCPsych/FRANZCP-style communication station: explain TRD without stigma, outline lithium augmentation with monitoring, address ECT fears, safety-net suicide risk, and check understanding.

communication
On this page & tools

Target exams

FRANZCPMRCPsychABPNMD-DNB

Target exams

FRANZCPMRCPsychABPNMD-DNB
Prompt
A 40-year-old woman with two failed adequate antidepressant trials wants a plain-language explanation of 'treatment-resistant depression', why lithium is being offered, what monitoring involves, when ECT would be considered, and how long treatment might continue after she improves.

Station brief

Format. Communication station, approximately 7–10 minutes active time after reading. You are the psychiatry registrar in the outpatient mood clinic. [3]

Candidate instructions. Explain what treatment-resistant depression means in plain language, why her previous trials count as adequate failures, why lithium augmentation is being recommended, what blood tests and side-effects to expect, when ECT might be discussed, and how you will monitor mood and safety. Check understanding and invite questions. The examiner plays the patient. [3]

Candidate scenario

She completed sertraline 150 mg for 8 weeks and venlafaxine XR 225 mg for 8 weeks with good adherence; PHQ-9 remains 18 with passive death wishes. Bipolar screen negative. She fears lithium is "for crazy bipolar people" and that ECT "scrambles the brain." She wants to know about "ketamine sprays from the internet." [1][3]

Marking domains

  • Empathy, structure, agenda-setting
  • Accurate non-stigmatising explanation of TRD (failed adequate trials, not personal failure)
  • Clear lithium plan: purpose, monitoring, toxicity red flags
  • Balanced ECT explanation without minimising or catastrophising
  • Safety-netting for suicidal thoughts
  • Corrects unsafe online ketamine use ideas
  • Checks understanding / teach-back [3]
Reveal assessor key

Open and agenda-set. Name time; ask her main worries first (lithium stigma, ECT fear, online ketamine). [3]

Explain TRD. "Treatment-resistant depression means depression that has not got much better after two proper full-dose medicine trials done for long enough with good adherence. It is a medical description of how treatment has gone so far — it is not a judgement that you are weak or 'beyond help'. Many people still improve with the next steps." [4][3]

Explain lithium. Lithium can be added to an antidepressant to boost benefit even when someone does not have bipolar disorder. We use blood tests to keep the level safe, and we check kidney and thyroid function. Early side-effects can include tremor or thirst; dangerous toxicity signs (severe tremor, confusion, vomiting, unsteadiness) need urgent care — especially if dehydrated. We review mood scores regularly.[1][3]

ECT. If depression becomes life-threatening, psychotic, or still severe despite further steps, ECT is a hospital treatment under anaesthetic with good evidence for severe depression. Temporary memory side-effects can occur; we discuss risks and benefits carefully — it is not a punishment and not random "scrambling."[2]

Online ketamine. Medical ketamine/esketamine, where available, is given in monitored settings because of blood pressure changes and dissociation. Unregulated internet products are unsafe; we can discuss licensed specialist pathways if appropriate later.[3]

Safety. If passive thoughts become plans or intent, contact crisis services/emergency the same day. Book early review; provide written information. Teach-back close. [3]

References

  1. [1]Nierenberg AA, Fava M, Trivedi MH, et al. A comparison of lithium and T(3) augmentation following two failed medication treatments for depression: a STAR*D report Am J Psychiatry, 2006.PMID 16946176
  2. [2]UK ECT Review Group Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis Lancet, 2003.PMID 12642045
  3. [3]Malhi GS, Bell E, Bassett D, et al. The 2020 Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders Aust N Z J Psychiatry, 2021.PMID 33353391
  4. [4]Rush AJ, Trivedi MH, Wisniewski SR, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report Am J Psychiatry, 2006.PMID 17074942